Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedApr 03, 2026
DataAggregated Company Financials
Companies23
  • 7D4.0%
  • 3M-20.5%
  • 1Y-16.3%
  • YTDn/a

The Pharma industry is up 7.2% in the last week, with Camurus up 5.8%. During this same period, the Flerie underperformed, falling 17%. However, the industry is down 16% over the past year. Looking forward, earnings are forecast to grow by 35% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Apr 2026SEK 41.7bSEK 5.3b-SEK 1,376,536,671.0055.9x-30.3x7.9x
Sun, 01 Mar 2026SEK 42.5bSEK 5.3b-SEK 1,354,331,873.0056.6x-31.4x8.1x
Tue, 27 Jan 2026SEK 54.3bSEK 5.3b-SEK 1,010,628,157.0070.9x-53.8x10.2x
Thu, 25 Dec 2025SEK 49.1bSEK 5.3b-SEK 531,735,157.0071x-92.3x9.3x
Sat, 22 Nov 2025SEK 49.1bSEK 5.3b-SEK 519,510,177.0069.3x-94.6x9.3x
Mon, 20 Oct 2025SEK 53.3bSEK 5.1b-SEK 405,183,865.0068x-131.5x10.5x
Wed, 17 Sep 2025SEK 56.0bSEK 5.1b-SEK 405,183,865.0076.3x-138.3x11x
Fri, 15 Aug 2025SEK 53.0bSEK 5.1b-SEK 318,636,364.0072.6x-166.3x10.5x
Sun, 13 Jul 2025SEK 55.9bSEK 4.8b-SEK 523,125,364.0076.3x-106.8x11.6x
Tue, 10 Jun 2025SEK 54.7bSEK 4.8b-SEK 574,327,610.6872.4x-95.2x11.3x
Thu, 08 May 2025SEK 53.8bSEK 4.8b-SEK 940,734,402.1779.1x-57.2x11.3x
Sat, 05 Apr 2025SEK 46.0bSEK 4.7b-SEK 809,558,890.2166.4x-56.8x9.8x
Mon, 03 Mar 2025SEK 54.9bSEK 4.7b-SEK 811,727,212.7079.6x-67.6x11.7x
Wed, 29 Jan 2025SEK 49.8bSEK 4.4b-SEK 810,030,609.04127.9x-61.4x11.2x
Fri, 27 Dec 2024SEK 50.1bSEK 4.4b-SEK 615,911,477.26125.3x-81.3x11.3x
Sun, 24 Nov 2024SEK 50.3bSEK 4.4b-SEK 619,523,619.23126.6x-81.1x11.3x
Tue, 22 Oct 2024SEK 53.8bSEK 4.3b-SEK 677,049,733.70136.8x-79.5x12.6x
Thu, 19 Sep 2024SEK 66.5bSEK 5.9b-SEK 1,169,990,593.21174.1x-56.8x11.3x
Sat, 17 Aug 2024SEK 70.1bSEK 5.9b-SEK 946,905,019.7090.4x-74x11.9x
Mon, 15 Jul 2024SEK 69.5bSEK 6.4b-SEK 835,140,932.6385.7x-83.2x10.9x
Wed, 12 Jun 2024SEK 62.1bSEK 6.4b-SEK 862,468,692.5777x-72x9.8x
Fri, 10 May 2024SEK 51.2bSEK 6.4b-SEK 803,411,675.6668.4x-63.8x8x
Sun, 07 Apr 2024SEK 51.4bSEK 6.2b-SEK 1,038,130,822.6777.9x-49.6x8.2x
Tue, 05 Mar 2024SEK 48.4bSEK 6.2b-SEK 1,038,055,453.8080.7x-46.6x7.8x
Thu, 01 Feb 2024SEK 68.7bSEK 9.5b-SEK 1,181,774,794.0064.9x-58.1x7.3x
Sat, 30 Dec 2023SEK 68.6bSEK 9.4b-SEK 1,184,243,785.0065.1x-58x7.3x
Mon, 27 Nov 2023SEK 61.2bSEK 9.5b-SEK 1,174,445,030.0054.4x-52.1x6.5x
Wed, 25 Oct 2023SEK 50.4bSEK 9.2b-SEK 1,143,109,792.00102.3x-44.1x5.5x
Fri, 22 Sep 2023SEK 51.6bSEK 9.2b-SEK 1,177,928,668.00135.7x-43.8x5.6x
Sun, 20 Aug 2023SEK 50.6bSEK 9.1b-SEK 1,308,392,355.0082.1x-38.7x5.5x
Tue, 18 Jul 2023SEK 48.5bSEK 8.4b-SEK 1,693,190,163.0084.4x-28.7x5.8x
Thu, 15 Jun 2023SEK 48.2bSEK 8.4b-SEK 1,728,123,085.0077.8x-27.9x5.8x
Sat, 13 May 2023SEK 49.7bSEK 8.2b-SEK 1,783,516,878.0090.8x-27.9x6.1x
Mon, 10 Apr 2023SEK 46.4bSEK 8.0b-SEK 1,793,930,310.0088x-25.8x5.8x
Price to Earnings Ratio

-25.8x


Total Market Cap: SEK 46.4bTotal Earnings: -SEK 1,793,930,310.00Total Revenue: SEK 8.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -73.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 9.0x is higher than the industry's current PS ratio of 8.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 13% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does Swedish Pharma compare with similar industries?

SE Market2.57%
Healthcare3.06%
Pharma4.01%
Pharma4.01%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 483.605.8%
+SEK 1.6b		-14.4%PE39.3x
SECARE SwedencareSEK 25.206.3%
+SEK 239.8m		-32.4%PE72.6x
ENZY EnzymaticaSEK 3.0823.2%
+SEK 140.8m		-23.0%PS13.9x
CESSA CessatechDKK 17.9413.5%
+DKK 39.8m		136.7%PS58.3x
DICOT Dicot PharmaSEK 0.425.8%
+SEK 46.2m		43.6%PB11.6x

Latest News

CAMX
SEK 483.60
Camurus
7D
5.8%
1Y
-14.4%

CAMX: FDA Review Of Resubmitted NDA Will Drive Future Upside

Analysts have trimmed their 12 month price target for Camurus from SEK 660 to SEK 610, citing updated assumptions that include revised revenue growth, profit margin and future P/E expectations. What's in the News Camurus issued earnings guidance for 2026, with expected revenues of SEK 2.6b to SEK 2.9b and an operating result of SEK 0.9b to SEK 1.2b, framed against internal 2025 expectations (Key Developments).
SECARE
SEK 25.20
Swedencare
7D
6.3%
1Y
-32.4%
KDV B
SEK 0.26
KDventures
7D
13.2%
1Y
-71.5%
ERMA
SEK 0.42
Enorama Pharma
7D
-6.0%
1Y
-80.0%
PILA
SEK 2.09
Pila Pharma
7D
54.4%
1Y
-32.3%
GABA
SEK 0.046
Gabather
7D
-2.6%
1Y
31.0%
FLERIE
SEK 29.70
Flerie
7D
-17.0%
1Y
-29.8%
ONCOZ
SEK 5.70
OncoZenge
7D
-3.4%
1Y
6.3%
IRLAB A
SEK 1.43
IRLAB Therapeutics
7D
-6.6%
1Y
-81.6%
CESSA
DKK 17.94
Cessatech
7D
13.5%
1Y
136.7%
KLAR
SEK 0.95
Klaria Pharma Holding AB (publ.)
7D
21.7%
1Y
-27.9%
ENZY
SEK 3.08
Enzymatica
7D
23.2%
1Y
-23.0%
CINPHA
SEK 16.30
Cinclus Pharma Holding
7D
-5.7%
1Y
43.0%
DICOT
SEK 0.42
Dicot Pharma
7D
5.8%
1Y
43.6%

Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?

Feb 03
Is Dicot Pharma (STO:DICOT) In A Good Position To Invest In Growth?
ODI
SEK 3.70
ODI Pharma
7D
-6.1%
1Y
63.7%